3-D Matrix,Ltd. (7777)

Market cap
¥54.7B
P/E ratio
59.2x
Three-D Matrix develops and sells medical devices and pharmaceuticals using exclusive MIT-licensed self-assembling peptide technology for surgery, tissue regeneration, and drug delivery.
Period EndTotal non-current assets (Million JPY)YoY (%)
Apr 30, 202594-0.21%
Apr 30, 202495-40.21%
Apr 30, 2023158+376.16%
Apr 30, 202233+2.79%
Apr 30, 202132+18.94%
Apr 30, 202027+5.14%
Apr 30, 201926+3.46%
Apr 30, 201825-29.60%
Apr 30, 201735-6.12%
Apr 30, 201638-93.76%
Apr 30, 2015605
AI Chat